The immune-suppressing drug used to prevent organ rejection in transplant patients, rapamycin, has been reported to reduce bone loss, inflammation and changes to oral bacteria in older mice with periodontal disease, according to a recent…

Dental topical anesthetics are among the most common drugs used in patient care, but their risks and adverse reactions are not always well known; in addition, many practitioners are not well versed in United States Food and Drug…

Oral health professionals located in areas with “moderate to substantial community transmission” of the novel coronavirus should wear N95 masks or respirators when performing procedures that increase the risk of transmission, such as those…

The United States Department of Health and Human Services announced it has secured 300 million doses of an experimental vaccine created by AstraZeneca in partnership with Oxford University as part of Operation Warp Speed. The influx of cash…

Healthcare workers at the University of Illinois Hospital and Health Sciences System, or UI Health, can participate in a national registry of clinicians working on the frontlines of the COVID-19 pandemic.

The United States Centers for Disease Control and Prevention (CDC) released updated guidelines for dental practices on May 19. The new guidance focuses on providing the most necessary dental services first and limiting the risk of an…

A team at New York University (NYU) is working to better understand the cellular and molecular mechanisms of how oral cancer cells invade nerves to help researchers identify new targets for treating patients with oral cancer and associated…

The United States Occupational Safety and Health Administration (OSHA) has released the following tips to help safeguard oral health professionals as they return to practice. Encourage clinicians and staff to stay home if sick…

A study published in eNeuro suggests taking antibiotics with opioids may increase the risk of opioid abuse. 

A COVID-19 vaccine—created by Moderna in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID)—seems to initiate an immune response in a Phase 1 trial, giving hope to the possibility of an effective vaccine in…